Download PDFPDF

OP0104 Tocilizumab: dose reduction or interval spacing – which proves a better tapering strategy for rheumatoid arthritis in clinical remission?
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address